NanoRibo (Shanghai) Biotechnology Co., Ltd.
PrivateLast Round
Early Funding
Feb 1, 2022
Company Overview
NanoRibo (Shanghai) Biotechnology Co., Ltd. operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was an Early Funding round in February 2022.
NanoRibo (Shanghai) Biotechnology Co., Ltd. is a biopharmaceutical company that specializes in the research and development of mRNA-based vaccines and therapeutic drugs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NanoRibo (Shanghai) Biotechnology Co., Ltd. Comparables
Compare NanoRibo (Shanghai) Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RongCan Biotech | 89% | |
| Therorna Inc. | 85% | |
| Suzhou CureMed Biopharma Technology Co., Ltd | 81% |
For institutional investors. Book with your work email.
NanoRibo (Shanghai) Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
NanoRibo (Shanghai) Biotechnology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shanghai Healthcare Capital | Early Funding |
NanoRibo (Shanghai) Biotechnology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NanoRibo (Shanghai) Biotechnology Co., Ltd.'s valuation, stock price, and market status.
Is NanoRibo (Shanghai) Biotechnology Co., Ltd. a public or private company?
NanoRibo (Shanghai) Biotechnology Co., Ltd. is a private company.
What is the current stock price of NanoRibo (Shanghai) Biotechnology Co., Ltd.?
NanoRibo (Shanghai) Biotechnology Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks NanoRibo (Shanghai) Biotechnology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NanoRibo (Shanghai) Biotechnology Co., Ltd. worth (valuation)?
Valuation information for NanoRibo (Shanghai) Biotechnology Co., Ltd. is not publicly available.
Can I buy NanoRibo (Shanghai) Biotechnology Co., Ltd. stock?
NanoRibo (Shanghai) Biotechnology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NanoRibo (Shanghai) Biotechnology Co., Ltd.'s last funding round?
NanoRibo (Shanghai) Biotechnology Co., Ltd.'s most recent funding round was Early Funding on February 1, 2022.
Who are the main investors in NanoRibo (Shanghai) Biotechnology Co., Ltd.?
Key investors in NanoRibo (Shanghai) Biotechnology Co., Ltd. include Shanghai Healthcare Capital.
Will NanoRibo (Shanghai) Biotechnology Co., Ltd. IPO soon?
No public IPO plans have been announced for NanoRibo (Shanghai) Biotechnology Co., Ltd..
How can I track NanoRibo (Shanghai) Biotechnology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in NanoRibo (Shanghai) Biotechnology Co., Ltd.'s shares on secondary markets.